Detailed Information on Publication Record
2009
Extended consensus on need and means to detect vascular variability disorders (VVDs) and vascular variability syndromes (VVSs)
HALBERG, Franz, Germaine CORNÉLISSEN, Kuniaki OTSUKA, Jarmila SIEGELOVÁ, Bohumil FIŠER et. al.Basic information
Original name
Extended consensus on need and means to detect vascular variability disorders (VVDs) and vascular variability syndromes (VVSs)
Name in Czech
Rozšířený konsenzus o potřebě a metodách jak detekovat poruchy cévní variability a syndromy cévní variability
Authors
HALBERG, Franz (840 United States of America, guarantor), Germaine CORNÉLISSEN (840 United States of America), Kuniaki OTSUKA (392 Japan), Jarmila SIEGELOVÁ (203 Czech Republic, belonging to the institution), Bohumil FIŠER (203 Czech Republic, belonging to the institution), Jiří DUŠEK (203 Czech Republic, belonging to the institution), Pavel HOMOLKA (203 Czech Republic, belonging to the institution), Salvador Sánchez DE LA PEŃA (484 Mexico) and R.B. SINGH (356 India)
Edition
World Heart Journal, Nova Science Publishers, 2009, 1556-4002
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/09:00056892
Organization unit
Faculty of Medicine
Keywords in English
BIOCOS; MESOR; MESOR-normotension; MESOR-hypertension; excessive pulse pressure; deficient heart rate variability; blood pressure ecphasia; outcome
Tags
International impact, Reviewed
Změněno: 17/4/2012 09:29, Mgr. Michal Petr
Abstract
V originále
Given that conventional health care practice is concerned mainly with high blood pressure (BP), and given the fact that other variability disorders -- circadian overswing, excessive pulse pressure, odd circadian BP timing and deficient heart rate (HR) variability (in their own right or in combination with MESOR-hypertension) -- are not diagnosed but contribute to cardiovascular disease risk, we wanted to find out 1. how many patients escape current diagnosis (and treatment), and 2. what are the risks such patients incur. A first available database consists of 297 patients (121 normotensives and 176 treated hypertensives). Each condition was considered separately, except that in the case of an excessive pulse pressure, all had also a high BP. In each case, the number of patients who have one, two, three or all four conditions (vascular variability disorders, VVDs) was counted. Their risk was assessed as the percentage incidence of morbid events (cerebral ischemic event, coronary artery disease, nephropathy, retinopathy) that occurred during the 6 years following the BP monitoring (used to diagnose the VVDs). Subjects had no history of morbidity at the time of monitoring.
Links
MSM0021622402, plan (intention) |
|